Ayush Dubey: Evolving Role of Immunotherapy in Head and Neck Cancer at MOSCON 2026
Ayush Dubey/LinkedIn

Ayush Dubey: Evolving Role of Immunotherapy in Head and Neck Cancer at MOSCON 2026

Ayush Dubey, Consultant Medical Oncologist at Sanjeevani Cancer Care Hospital, shared on LinkedIn:

“Honored to be invited as faculty at 9th MOSCON for a panel discussion on Perioperative and Adjuvant Immunotherapy in Head and Neck Cancer, expertly moderated by Dr. Atul Sharma sir.

It was a privilege to exchange perspectives with esteemed colleagues and contribute to discussions on the evolving role of immunotherapy in head and neck oncology.

The event became even more special with the alumni meet of my institute, providing an opportunity to reconnect with my respected teachers, seniors, juniors, and friends.

Grateful for the mentorship, lifelong relationships, and shared commitment to advancing cancer care.”

Ayush Dubey

Read also “Tumor Microenvironment: Why It Matters for Cancer Immunotherapy” on OncoDaily.

Ayush Dubey: Evolving Role of Immunotherapy in Head and Neck Cancer at MOSCON 2026

Medically reviewed Jul 21, 2026 by Marine Rushanyan, MD